Abstract
The introduction of ultrasound screening combined with the increasingly elderly population means that the number of small abdominal aortic aneurysms (AAAs) detected is expected to increase over the next decade. At present open or endovascular surgery are the only treatment options for AAA. In this mini-review we discuss the rationale and ongoing attempts to develop non-surgical therapies for AAA.
Keywords: Abdominal aortic aneurysm, medication
Current Vascular Pharmacology
Title: Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm
Volume: 7 Issue: 2
Author(s): Jonathan Golledge, Ronald L. Dalman and Paul E. Norman
Affiliation:
Keywords: Abdominal aortic aneurysm, medication
Abstract: The introduction of ultrasound screening combined with the increasingly elderly population means that the number of small abdominal aortic aneurysms (AAAs) detected is expected to increase over the next decade. At present open or endovascular surgery are the only treatment options for AAA. In this mini-review we discuss the rationale and ongoing attempts to develop non-surgical therapies for AAA.
Export Options
About this article
Cite this article as:
Golledge Jonathan, Dalman L. Ronald and Norman E. Paul, Developments in Non-Surgical Therapies for Abdominal Aortic Aneurysm, Current Vascular Pharmacology 2009; 7 (2) . https://dx.doi.org/10.2174/157016109787455608
DOI https://dx.doi.org/10.2174/157016109787455608 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Novel Therapeutic Approaches Targeting Matrix Metalloproteinases in Cardiovascular Disease
Current Topics in Medicinal Chemistry Association between HbA1C (Glycated Hemoglobin) and Clinical Outcomes in Patients with Subarachnoid Hemorrhage After Neuro-intervention
Current Neurovascular Research Lithium and its Neuroprotective and Neurotrophic Effects: Potential Treatment for Post-Ischemic Stroke Sequelae
Current Drug Targets Radiologic Findings of IgG4-Related Disease
Current Immunology Reviews (Discontinued) Dealing with the Substance Abuse Epidemic and Infective Endocarditis:Clinical, Immunologic and Pathogenetic Aspects
Current Vascular Pharmacology Clinical and Forensic Signs Related to Cocaine Abuse
Current Drug Abuse Reviews A Cyclooxygenase-2 Inhibitor Reduces Vascular Wall Thickness and Ameliorates Cognitive Impairment in a Cerebral Small Vessel Diseases Rat Model
Current Alzheimer Research Cardiovascular Complications in Patients with Turner’s Syndrome
Current Pharmaceutical Design Fragmented ECG as a Risk Marker in Cardiovascular Diseases
Current Cardiology Reviews Impact of the Renin-Angiotensin-Aldosterone-System on Cardiovascular and Renal Complications in Diabetes Mellitus
Current Vascular Pharmacology Virus-Associated Vasculitides
Current Immunology Reviews (Discontinued) Recent Advances in Management of Diabetic Macular Edema
Current Diabetes Reviews Atherosclerotic and Non-Atherosclerotic Coronary Heart Disease in Women
Current Medicinal Chemistry Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry Pharmacotherapy for Intermittent Claudication: From Consensus-Based to Evidence-Based Treatment
Vascular Disease Prevention (Discontinued) Biologic Agents in the Treatment of Psoriasis
Recent Patents on Inflammation & Allergy Drug Discovery CypA: A Potential Target of Tumor Radiotherapy and/or Chemotherapy
Current Medicinal Chemistry Renovascular Hypertension: Lesion Detection, Patient Selection, Treatment Options and Results
Current Hypertension Reviews Right Heart Catheterization Through Persistent Left Superior Vena Cava, an Extremely Rare Procedure and Review of Current Literature
Current Cardiology Reviews Spectrophotometric Quantification of Bilirubin in Hemorrhagic Spinal Fluid using an Innovative Algorithm
Medicinal Chemistry